Shares of Danaher Corp. DHR advanced 1.43% to $238.20 Monday, on what proved to be an all-around mixed trading session for ...

Discover why Danaher is a strong investment choice with its wide moat business model, M&A strategy, and growth potential for ...

Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on ...

In a report released on January 2, Patrick B Donnelly from Citi maintained a Buy rating on Danaher (DHR – Research Report), with a price target ...

Danaher Corp (DHR) stock saw a modest uptick, ending the day at $229.81 which represents a slight increase of $0.26 or 0.11% from the prior close of $229.55. The stock opened at $230.72 and touched a ...

A line-up of experts across academia, pharma, and healthcare came together to discuss the impact and challenges of ...

We recently compiled a list of the 8 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where ...

On Tuesday, Danaher Corp (DHR) stock saw a decline, ending the day at $229.55 which represents a decrease of $-0.10 or -0.04% from the prior close of $229.65. The stock opened at $ and touched a low ...

Modus Advisors LLC bought a new stake in Danaher Co. (NYSE:DHR – Free Report) in the fourth quarter, according to its most ...

Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The stock's rise snapped a three-day losing streak.

The company has topped estimates by 9.58%, on average, in the last two quarters. For the most recent quarter, Danaher was expected to post earnings of $1.56 per share, but it reported $1.71 per ...